Skip to main content
$60.79 $0.12 (19.8%)

12:00 PM EDT on 10/23/20

Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Current Price $60.79 Mkt Cap $76.2B
Open $63.38 P/E Ratio 0.00
Prev. Close $60.79 Div. (Yield) $2.67 (4.4%)
Daily Range $60.76 - $63.64 Volume 30,965,444
52-Wk Range $59.65 - $85.97 Avg. Daily Vol. 9,686,611

Caps

How do you think NASDAQ:GILD will perform against the market?

Add Stock to CAPS Watchlist

All Players

3,403 Outperform
88 Underperform
 

All-Star Players

638 Outperform
12 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:GILD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NHWeston102 (77.54)
Submitted May 02, 2020

Because the coronovirus has more patience than the American public...

nhatch3353 (61.36)
Submitted March 23, 2016

Patent problems and trouble with cancer drug trials.

Recent Community Commentary

Read the most recent pitches from players about GILD.

Recs

0
Member Avatar Flem747 (< 20) Submitted: 9/21/2020 5:20:32 PM : Outperform Start Price: $63.99 NASDAQ:GILD Score: -10.18

Strong interest from Remdesivir. Positive outcome from bladder cancer drug study. Pending acquisition of Immunomedics looks positive.

Recs

0
Member Avatar TMFZhiyuanSun (37.01) Submitted: 9/13/2020 8:41:06 PM : Outperform Start Price: $65.40 NASDAQ:GILD Score: -8.71

Good hedge against failure of COVID-19 vaccines. Solid pipeline.

Recs

0
Member Avatar MaestroFool (96.96) Submitted: 9/4/2020 12:01:22 PM : Underperform Start Price: $65.36 NASDAQ:GILD Score: +8.96

I have a real hard time imagining that Gilead will have sold enough Remdesivir to make this stock a market performer much less a market *beater.* I do continue to own shares in my real portfolio though, so I'm happy to be proven wrong. Underperform.

Leaderboard

Find the members with the highest scoring picks in GILD.

Score Leader

BrianMotleyFool

BrianMotleyFool (56.79) Score: +536.73

The Score Leader is the player with the highest score across all their picks in GILD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WilliamCrook2003 70.63 1/29/2007 1/25/2012 Outperform 5Y $13.42 +353.07% +158.12% +194.95 1 Comment
UrineLuck73 < 20 1/29/2007 Outperform NS $13.42 +353.07% +158.12% +194.95 0 Comment
predragj 42.26 1/30/2007 Outperform NS $13.59 +347.33% +157.82% +189.50 0 Comment
JSergeant 71.15 7/3/2006 Outperform 3Y $12.71 +378.42% +189.08% +189.34 0 Comment
mxdfool < 20 12/15/2006 Outperform 5Y $13.65 +345.28% +156.94% +188.35 0 Comment
betsypurcell < 20 1/24/2007 Outperform NS $13.67 +344.67% +156.71% +187.96 0 Comment
rmarinchek < 20 1/25/2007 Outperform 3W $13.77 +341.33% +155.15% +186.18 0 Comment
Redskins2k9 < 20 1/25/2007 Outperform 5Y $13.77 +341.33% +155.15% +186.18 0 Comment
opveiby 80.28 1/25/2007 Outperform 5Y $13.77 +341.33% +155.15% +186.18 0 Comment
jer8899 68.11 1/23/2007 Outperform NS $13.74 +342.30% +156.74% +185.56 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GILD.